γ-Tocotrienol protects against ovariectomy-induced bone loss via mevalonate pathway as HMG-CoA reductase inhibitor.

Abstract

γ-Tocotrienol (GT3), an analogue of vitamin E, has gained increasing scientific interest recently as it provides significant health benefits. GT3 exerts its biological effects not only by virtue of antioxidant properties but also by inhibiting hydroxy-methyl-glutaryl-coenzyme A (HMG-CoA) reductase. Studies have reported that the mevalonate pathway is relevant for bone metabolism and HMG-CoA reductase inhibitors can increase bone mass and are useful in osteoporosis therapy. However, whether it is involved in the bone anabolic activity of GT3 is not clear. This study was conducted to investigate the ability of GT3 to protect against ovariectomy-induced bone loss, as well as the correlation between the protections and mevalonate pathway. Results showed that mice supplemented with 100mg/kg emulsified GT3 via subcutaneous injection once per month for three months were significantly protected from ovariectomy-induced bone loss as evaluated by various bone structural parameters, bone metabolic gene expression levels and serum levels of biochemical markers for bone resorption and bone formation. Importantly, the effect of GT3 on preventing against ovariectomy-induced bone loss could be reversed by daily supplementation with mevalonate, indicating that GT3 may via an HMG-CoA reductase-dependent mechanism to protect against ovariectomy-induced bone loss. Our results suggest that GT3 is suitable as dietary supplement and has potential as an alternative drug to treat or prevent osteoporosis.

• Authors: Lili Deng, Yuedi Ding, Ying Peng, Yu Wu, Jun Fan, Wenxin Li, Runlin Yang, Meiling Yang, Qiang Fu
• Journal: Bone (Bone) Vol. 67 Pg. 200-7 (Oct 2014) ISSN: 1873-2763 [Electronic] United States
• PMID: 25019595 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: Copyright © 2014 Elsevier Inc. All rights reserved.

Chemical References

• Chromans
• Hydroxymethylglutaryl-CoA Reductase Inhibitors
• Vitamin E
• plastochromanol 8
• Mevalonic Acid

Topics

• Animals
• Bone Resorption (etiology, prevention & control)
• Chromans (therapeutic use)
• Female
• Hydroxymethylglutaryl-CoA Reductase Inhibitors (therapeutic use)
• Mevalonic Acid (metabolism)
• Mice
• Mice, Inbred C57BL
• Ovariectomy
• Vitamin E (analogs & derivatives, therapeutic use)